WHO ICTRP trial
PrasugrEl moNotherapy after DrUg eLUting stent deployMent as a Management Of…
JPRN-UMIN000028023 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000028023 |
|---|---|
| Public title | PrasugrEl moNotherapy after DrUg eLUting stent deployMent as a Management Of patients who are uNsuitable for lOng-term dual antiplatelet therapy |
| Scientific title | PrasugrEl moNotherapy after DrUg eLUting stent deployMent as a Management Of patients who are uNsuitable for lOng-term dual antiplatelet therapy - PENDULUM mono |
| Primary sponsor | Toho University Ohashi Medical Center |
| Secondary sponsors | Daiichi Sankyo Co., LTD |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Others,meta-analysis etc |
| Phase | Not applicable |
| Countries | Japan |
| Conditions | Patient who underwent placement of a drug elution stent by percutaneous coronary intervention, have a high bleeding risk, and are considered to have a medical difficulty in receiving long-term administration of Aspirin |
| Registration date | Jan 7, 2017 |
| Target size | 1100 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: